LPX Lipoxen

RNS Number:6733O
Lipoxen PLC
25 February 2008



25th February 2008

Lipoxen plc

Lipoxen plc presenting at:

Sachs Associates, 7th Annual North America Forum for Investing & Partnering in 
Biotech

London, UK, 25th February, 2008 - Lipoxen PLC (AIM: LPX) a bio-pharmaceutical
company specialising in the development of high value differentiated
biologicals, vaccines and oncology drugs, today announces that M. Scott Maguire,
Chief Executive Officer, will be presenting at the Sachs Associates, 7th Annual
North America Forum for Investing & Partnering in Biotech at the Fairmont Copley
Plaza on 25th February, 2008 at 11am EST.

The presentation and further company information will be available at
www.lipoxen.com


Enquiries:

Lipoxen plc                                                +44 (0)20 7691 3583
M. Scott Maguire, Chief Executive Officer
Colin Hill, Finance Director

Landsbanki Securities (UK) Limited                         +44 (0)20 7426 9000
Shaun Dobson
Claes Spang

Citigate Dewe Rogerson                                     +44 (0)20 7638 9571
David Dible                                     
Emma Palmer





                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCPUUPAPUPRGPA

Lipoxen (LSE:LPX)
Historical Stock Chart
From Jun 2024 to Jul 2024

Lipoxen (LSE:LPX)
Historical Stock Chart
From Jul 2023 to Jul 2024